Literature DB >> 302812

Effect of acetylsalicylic acid on gastric mucosa. II. Mucosal ATP and phosphocreatine content, and salicylate effects on mitochondrial metabolism.

J G Spenney, M Bhown.   

Abstract

The effects of acetylsalicylic acid on gastric mucosal ATP and phosphocreatine and mucosal O2 consumption were studied using in vitro bullfrog gastric mucosa. Electrophysiological parameters (potential difference and resistance) changed rapidly after exposure to 10 or 20 mM acetylsalicylic acid at pH 3.0, 4.0, or 6.0 in the mucosal solution. ATP and phosphocreatine content decreased rapidly after exposure. Control mucosae contained 11.8 +/- 0.98 nmoles of ATP and 11.5 +/- 0.68 nmoles of phosphocreatine per mg of protein. ATP content decreased 21% and phosphocreatine decreased 45% after 15 to 30 min of exposure. Longer durations of exposure reduced both ATP and phosphocreatine to 10 to 15% of control levels. O2 consumption was increased during the first 15 to 30 min after exposure to acetylsalicylate. Longer durations of exposure reduced O2 consumption to near control levels. Study of isolated mitochondria confirmed that acetylsalicylate itself did not significantly affect mitochondrial respiration, respiratory control ratio, or ADP:O ratio. Salicylate had a biphasic effect which was concentration dependent. Salicylate initially stimulated and later inhibited mitochondrial respiration. Using various substrates the site of inhibition appeared to be located in the segment of the respiratory chain between coenzyme Q and cytochrome c1.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 302812

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

Review 1.  Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management.

Authors:  S Szabo; W F Spill; K D Rainsford
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 2.  A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity.

Authors:  T Mahmud; D L Scott; I Bjarnason
Journal:  Ann Rheum Dis       Date:  1996-04       Impact factor: 19.103

3.  Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.

Authors:  S Somasundaram; S Rafi; J Hayllar; G Sigthorsson; M Jacob; A B Price; A Macpherson; T Mahmod; D Scott; J M Wrigglesworth; I Bjarnason
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

4.  Drug-induced gastric mucosal injury.

Authors:  D Fromm
Journal:  World J Surg       Date:  1981-03       Impact factor: 3.352

5.  Profiling cellular bioenergetics, glutathione levels, and caspase activities in stomach biopsies of patients with upper gastrointestinal symptoms.

Authors:  Ali S Alfazari; Bayan Al-Dabbagh; Wafa Al-Dhaheri; Mazen S Taha; Ahmad A Chebli; Eva M Fontagnier; Zaher Koutoubi; Jose Kochiyi; Sherif M Karam; Abdul-Kader Souid
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

6.  Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis.

Authors:  Gabriella Varga; Melinda Ugocsai; Petra Hartmann; Norbert Lajkó; Réka Molnár; Szilárd Szűcs; Dávid Kurszán Jász; Dániel Érces; Miklós Ghyczy; Gábor Tóth; Mihály Boros
Journal:  Inflammopharmacology       Date:  2017-04-27       Impact factor: 4.473

Review 7.  Gastroprotection and nonsteroidal anti-inflammatory drugs (NSAIDS). Rationale and clinical implications.

Authors:  J Hayllar; A Macpherson; I Bjarnason
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

8.  Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?

Authors:  W E Roediger; S Millard
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

9.  Reye's syndrome and aspirin.

Authors:  P H Rowe
Journal:  J R Soc Med       Date:  1987-05       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.